This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcipar, I. S.
Right arrow Articles by Marcipar, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcipar, I. S.
Right arrow Articles by Marcipar, A. J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2001, p. 802-805, Vol. 8, No. 4
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.4.802-805.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Antibody Maturation in Trypanosoma cruzi-Infected Rats

Iván S. Marcipar,1,* Marikena G. Risso,1 Ariel M. Silber,1 Silvia Revelli,2 and Alberto J. Marcipar1

INTEBIO, Facultad de Bioquímica y Cs. Biológicas, Universidad Nacional del Litoral, 3000 Santa Fe,1 and Instituto de Inmunología, Facultad de Medicina, Universidad Nacional de Rosario, 2000 Rosario,2 Argentina

Received 18 January 2001/Returned for modification 26 February 2001/Accepted 9 May 2001

The study of antibody avidity changes during infection has improved the understanding of the pathologic processes involved in several infectious diseases. In some infections, like toxoplasmosis, this information is being used for diagnostic purposes. Results of the evolution of antibody avidity for different specific antigens in Trypanosome cruzi-infected rats are presented. A Western blotting technique, combined with avidity analysis to identify antigens that elicit high-avidity antibodies, is suggested. In this system, antibodies showed high avidity values only during the chronic phase of infection and only in relation to antibodies against 21-, 33-, 41-, 42-, 56-, 58-, 66-, and 72-kDa antigens. Finally, a 97-kDa T. cruzi antigen, which was recognized by high-avidity antibodies and occurred in noninfected rats, was identified. These results allow us to evaluate the different antigens in chagasic infection. Our results show that with the correct choice of antigen it is possible to detect differences in maturation of antibodies and to discriminate, in an experimental model, between recent (acute) and chronic infections.


* Corresponding author. Mailing address: INTEBIO, Ciudad Universitaria, Paraje El Pozo C. C. 530 CP, 3000 Santa Fe, Argentina. Phone: (54) (42) 4575216, ext. 125. Fax: (54) (42) 4575219. E-mail: marcipar{at}fbcb.unl.edu.ar.


Clinical and Diagnostic Laboratory Immunology, July 2001, p. 802-805, Vol. 8, No. 4
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.4.802-805.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.